BRAIN & DEVELOPMENT is a prestigious academic journal published by ELSEVIER, renowned for its pivotal contributions to the fields of developmental neuroscience, neurology, and pediatrics. Established in 1979, this journal has become an essential resource for researchers and clinicians alike, as it explores the complexities of brain development and associated neurological disorders in children. With an impactful focus on advancing scientific understanding, BRAIN & DEVELOPMENT is currently ranked in the Q3 quartile in Developmental Neuroscience and Clinical Neurology and Q2 in Pediatrics, reflecting its significance within the medical community. Its ISSN 0387-7604 and E-ISSN 1872-7131 underline its established presence in academic literature. While the journal does not offer open access options, it continues to be a key platform for disseminating new research findings and fostering innovation in the understanding of pediatric neurological health. The journal's commitment to quality research is further evidenced by its ongoing publication trajectory up until 2024, making it a vital source of knowledge for students, professionals, and educators in related fields.

NEUROPEDIATRICS is a prominent academic journal published by GEORG THIEME VERLAG KG, dedicated to advancing the understanding and treatment of neurological disorders in children. Established in 1980, this journal has consistently provided a platform for innovative research and clinical practice in the fields of pediatrics and neurology, culminating in its recognition across various rankings; it holds a Q2 rating in Pediatrics, Perinatology and Child Health, and Q3 in both Medicine (miscellaneous) and Neurology (clinical) as of 2023. While NEUROPEDIATRICS is not an open access journal, it remains a crucial resource for researchers, clinicians, and students who seek cutting-edge insights and evidence-based practices in the management of pediatric neurological issues. As a result, NEUROPEDIATRICS plays an indispensable role in shaping future research directions and improving health outcomes in this vital field.

NEUROLOGIC CLINICS, published by W B SAUNDERS CO-ELSEVIER INC, stands as a leading journal in the field of clinical neurology, boasting an impressive impact factor that reflects its significant contributions to neurological research and clinical practice. With an ISSN of 0733-8619 and E-ISSN of 1557-9875, this journal provides a critical platform for the dissemination of innovative research, case studies, and reviews focusing on various aspects of neurology, from diagnosis to treatment interventions. As part of its commitment to advancing the understanding of neurological disorders, NEUROLOGIC CLINICS is categorized in the Q2 quartile for Neurology (clinical) in 2023, indicating its robust standing within the academic community. It is recognized for its rigorous peer-review process and is indexed in Scopus, ranking #147 out of 400 in its field with a notable 63rd percentile. The journal, which dates back to 1983 and continues to publish vital findings up to 2024, is an invaluable resource for researchers, healthcare professionals, and students dedicated to enhancing their knowledge and clinical skills in neurology. Subscribe now to stay abreast of current advancements and expand your expertise in this dynamic field.

CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE is a prominent scientific journal focusing on the fields of neurology and neurosurgery, published by the esteemed Czech Medical Society. Since its inception in 1973, the journal has aimed to disseminate significant research and advancements in clinical neurology and surgery, contributing to the body of knowledge for professionals and researchers in these fields. Operating under a non-open access model, it maintains a dedicated readership interested in valuable insights from the latest studies and clinical practices. The journal is currently classified in the Q4 category in both Neurology (Clinical) and Surgery, reflecting its ongoing efforts to provide a platform for impactful research, despite being ranked in the lower percentiles within Scopus. Based in Prague, Czech Republic, this journal not only serves as a repository of clinical findings but also encourages collaboration and scholarly dialogue among neurologists and neurosurgeons, driving the field towards further innovations in patient care. With coverage extending from 1973 to 2024, it stands as a key resource for those committed to advancing neurological and surgical sciences.

The JOURNAL OF CHILD NEUROLOGY is a distinguished publication in the critical fields of neurology and pediatrics, published by SAGE PUBLICATIONS INC. With its ISSN 0883-0738 and E-ISSN 1708-8283, this journal has been a pivotal resource since its inception in 1986, serving the needs of researchers, clinicians, and students dedicated to advancing the understanding and treatment of neurological disorders in children. As evidenced by its impressive Q2 rankings in both Neurology (clinical) and Pediatrics, Perinatology, and Child Health, the journal has established a reputable position within the academic community, ranking in the 75th percentile for pediatrics and the 53rd percentile for clinical neurology. This periodical not only contributes to the body of knowledge in child neurology but also promotes interdisciplinary collaboration, engaging a global audience through innovative research articles and case studies. Although the journal is not open access, it remains committed to disseminating high-quality research aimed at improving pediatric health outcomes, making it an essential read for professionals and researchers dedicated to this crucial area of medicine.

REVUE NEUROLOGIQUE, published by MASSON EDITEUR, is a prestigious academic journal that plays an essential role in the field of neurology. With a rich history spanning from 1946 to the present, this journal focuses on both foundational and clinical aspects of neurology, underscoring its significance within the medical community. Holding an impressive Q2 ranking in both general and clinical neurology categories as of 2023, REVUE NEUROLOGIQUE is recognized for its contribution to advancing neurological science, as evidenced by its Scopus rankings, with a notable position in the 62nd percentile for clinical neurology. The journal fosters an environment for rigorous research and is instrumental for professionals and scholars aiming to stay abreast of the latest developments in neurological disorders and treatments. Although it is not an open-access publication, it offers a wealth of vital research through its issues, appealing to those engaged in both clinical practice and academic research in neurology.

Neurology and Therapy, published by SPRINGER LONDON LTD, stands as a pivotal platform for researchers and practitioners in the field of neurology and its therapeutic applications. This Open Access journal, active since 2012, facilitates the dissemination of innovative studies and cutting-edge findings aimed at improving neurological health. With an impressive ranking in the 2023 Scopus Rankings, where it holds a Q2 category in Neurology and a Q1 category in Clinical Neurology, it underscores its prominence in advancing neurological research. The journal's intriguing scope encompasses a wide-ranging exploration of neurological disorders, treatment methodologies, and healthcare strategies, making it a valuable resource for those vested in enhancing patient outcomes. With an appealing average impact factor, readers are encouraged to dive into the latest advancements and engage with the scholarly discussions that are shaping the future of neurology.

NEUROMUSCULAR DISORDERS is a premier academic journal published by PERGAMON-ELSEVIER SCIENCE LTD, focusing on the latest research and developments in the fields of neurology, genetics, and pediatric health. With an ISSN of 0960-8966 and an E-ISSN of 1873-2364, this journal has established a significant presence since its inception in 1991, and it continues to contribute to the scientific community with its impactful findings and reviews. The journal boasts a commendable impact factor, reflected in its placement in the Q2 category for Clinical Genetics and Neurology, as well as its positioning in the top tier Q1 for Pediatrics, Perinatology and Child Health according to the latest quartile assessments. With Scopus rankings such as Rank #71/330 in Pediatrics and Rank #51/99 in Clinical Genetics, NEUROMUSCULAR DISORDERS is recognized for its contribution to advancing knowledge in neuromuscular diseases. The journal is essential for researchers, clinicians, and students interested in the intricate relationship between genetics and neurological disorders, providing valuable insights that drive innovation and improve patient care.

NEUROLOGY, published by Lippincott Williams & Wilkins, stands as a premier journal in the field of neurology, holding an esteemed Q1 category ranking in clinical neurology as of 2023. Established in 1951, this journal has been a critical resource for the dissemination of cutting-edge research and clinical advancements, with an impressive Scopus rank of 24 out of 400, placing it in the 94th percentile among its peers. NEUROLOGY serves as a vital platform for neurologists, researchers, and medical professionals seeking to stay abreast of the latest findings and innovations in the treatment and understanding of neurological disorders. With its rigorous peer-review process and commitment to excellence, NEUROLOGY remains essential reading for all individuals dedicated to advancing the science and practice of neurology, contributing significantly to the ongoing dialogue in this vital area of medicine.

EPILEPSIA is a premier academic journal published by Wiley, with a storied history dating back to 1909, making it a cornerstone in the field of epilepsy research and neurology. With an impressive impact factor reflecting its robust contribution to the academic community, EPILEPSIA is categorized in the top quartile (Q1) in both neurology and clinical neurology as of 2023, underscoring its significance and prestige. The journal is ranked #15 out of 192 in Neuroscience & Neurology and #34 out of 400 in Medicine & Neurology (clinical) within Scopus, indicating its essential role in advancing knowledge and treatments related to epilepsy. Researchers and clinicians are encouraged to contribute groundbreaking studies, case reports, and reviews that inform best practices and improve patient outcomes. Although EPILEPSIA currently does not offer open access options, its detailed exploration of both fundamental and clinical aspects of epilepsy ensures wide dissemination of crucial findings among professionals and students alike, furthering the understanding and management of this complex condition.